KW-136

· Kawin Technology Share-holding Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KW-136, covering 2018-01-31 to 2018-01-31. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of KW-136 and Sofosbuvir for Treatment of Chronic Hepatitis C [Phase 2]